Sclerosis multiplex (SM): ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• CD20 17
• CD19 10
• PPAR 0
• NLRP3 0
• STAT3 0
• BCMA 13
• BTK 1
• IL-17 0
• NRF2 0
• TNF 0
• AQP4 0
• GLP-1 2
• AMPK 0
• BDNF 1
• AKT 0
• IL-6 0
• mTOR 0
• CD40 0
• JAK 0
• PI3K 0
• STING 0
• TREM2 0
• PD-1 0
• IL-1 0
• IL-4 0
• SIRT1 0
• TLR4 0
• AXL 0
• CGRP 0
• CSF1R 0
• HIF-1 0
• IL-23 0
• VEGF 1
• COX-2 0
• CTLA-4 0
• CXCR4 0
• ERK 0
• HMGB1 0
• HSP90 0
• PD-L1 0
• TYK2 1
• APOE 0
• CCR5 0
• CTNNB1 0
• EGFR 0
• FOXP3 0
• GPX4 0
• IDO1 0
• JNK 0
• PARP 0
• PTEN 0
• TP53 1
• ACE2 0
• APP 0
• BCL-2 0
• BRD4 0
• C9orf72 0
• CDK4/6 0
• G6PD 0
• HDAC 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NIAID · F31

  Dysregulation of Aging Regulatory T-Cell Response in Autoimmune Disease

  Utah State Higher Education System--University of Utah· Salt Lake City, Egyesült Államok· 38 914 USD awarded in fiscal year 2026· until 2029. okt.

• U.S. Department of Veterans Affairs · IK2

  Remotely administered tDCS to improve cognitive function in Veterans with mTBI and PTSD

  Philadelphia Va Medical Center· Philadelphia, Egyesült Államok· until 2031. szept.

• U.S. Department of Veterans Affairs · I01

  Targeting Blood Retinal Barrier Dysfunction in Multiple Sclerosis

  Charlie Norwood Va Medical Center· Augusta, Egyesült Államok· until 2030. szept.

• NIH NIAID · F31

  Genetic and cellular mechanisms underlying resistance to gammaherpesvirus infection

  University of Vermont & St Agric College· Burlington, Egyesült Államok· 34 654 USD awarded in fiscal year 2026· until 2028. szept.

• NIH NINDS · R01

  Astrocyte exosomes as senescence biomarkers and drivers of progression in multiple sclerosis patients

  Yale University· New Haven, Egyesült Államok· 619 252 USD awarded in fiscal year 2026· until 2031. aug.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-GF

  Artificial intelligence and WeArables for the undeRstanding and Evaluation of Multiple Sclerosis (AWARE-MS)

  Scuola Superiore di Studi Universitari e di Perfezionamento S Anna· Pisa, Olaszország· EU contribution 420 751 EUR· until 2030. márc.· 2 countries

• European Commission (Horizon Europe) · HORIZON-ERC

  Astrocytic exhaustion underlies chronic progression in autoimmune inflammation of the central nervous system (AXhaustMS)

  Klinikum Der Technischen Universität München (Tum Klinikum)· Muenchen, Németország· EU contribution 1 638 843 EUR· until 2032. jan.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Molecular regulation of the axon–myelin interface in development and repair (MInDRe)

  The University of Edinburgh· Edinburgh, Egyesült Királyság· EU contribution 260 348 EUR· until 2029. jan.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Harnessing engineered lipid nanoparticles to tame autoimmune neuroinflammation by inducing regulatory T cells through CNS myeloid reprogramming (LipoTAME)

  Vrije Universiteit Brussel· Bruxelles / Brussel, Belgium· EU contribution 200 400 EUR· until 2029. jan.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC

  Targeting myeloid cell states, actions and interactions in neuroinflammation (TACO)

  Ludwig-Maximilians-Universitaet Muenchen· Planegg, Németország· EU contribution 2 471 050 EUR· until 2031. dec.

10 of 663 running projects, newest first. Listed amounts together: 294,6 M USD + 130,5 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Leállított, visszavont és felfüggesztett vizsgálatok, a szponzor által a regiszterben megadott okkal, szó szerint idézve.

• Felfüggesztve

  Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues

  NCT06171152· University of Chicago· Frissítve: 2026. márc. 30.

  “Study pending amendment”A regiszter szövege, változtatás nélkül. Forrás

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

• Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues

  NCT06171152· University of Chicago· Forrás

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 16
• Mendelian Randomization Analysis 66
• CRISPR-Cas Systems 3
• Gene Expression Profiling 39
• Sequence Analysis, RNA 6
• Whole Genome Sequencing 1
• Exome Sequencing 3
• Proteomics 34
• Metabolomics 21
• Mass Spectrometry 12
• Flow Cytometry 29
• Immunohistochemistry 10
• Xenograft Model Antitumor Assays 2
• Positron-Emission Tomography 29
• Magnetic Resonance Imaging 570
• Machine Learning 43
• Deep Learning 33
• Cohort Studies 183
• Genome-Wide Association Study 84

• Latent Representation Learning from 3D Brain MRI for Latent Analysis and Prediction in Multiple Sclerosis.

  Neuroinformatics, 2026. nov.

• High cortical lesion burden moderates the association between brain networks and processing speed in older adults with multiple sclerosis.

  Brain Imaging Behav, 2026. nov.

• The role of network connectivity and transcriptomic vulnerability in shaping gray matter atrophy in multiple sclerosis.

  Sci Adv, 2026. nov.

• Altered glutamate homeostasis in paramagnetic rim lesions of patients with multiple sclerosis.

  Imaging Neurosci (Camb), 2026. nov.

• Optimized multi-echo gradient echo MRI of the lumbosacral spinal cord to investigate atrophy, lesions, and disability in relapsing-remitting multiple sclerosis.

  Imaging Neurosci (Camb), 2026. nov.

• Impact of 2024 Revisions of Multiple Sclerosis Diagnostic Criteria in People With Radiologically Isolated Syndrome.

  Neurology, 2026. nov.

  Marcello Moccia

• Cortical Hierarchical Disorganization and Transcriptomic Associations in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders Revealed by Morphometric INverse Divergence Network Gradients.

  CNS Neurosci Ther, 2026. nov.

• EPR-based Assessment of Gadolinium-based Contrast Agent Retention and Gadolinium Transchelation in Inflamed Murine Brain.

  Invest Radiol, 2026. nov.

• Comparison of 7-T and 3-T MRI for the Detection of Multiple Sclerosis Lesions.

  Radiology, 2026. nov.

• Bilateral Internuclear Ophthalmoplegia Caused by Minor Head Injury: A Case Report.

  Acta Neurol Taiwan, 2026. okt.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.